Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

CONTEXT: The effect of sotagliflozin (a dual sodium–glucose cotransporter [SGLT] 2 and SGLT1 inhibitor) on intestinal glucose absorption has not been investigated in humans. OBJECTIVE: To measure rate of appearance of oral glucose (R(a)O) using a dual glucose tracer method following standardized mix...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Powell, David R, Zambrowicz, Brian, Morrow, Linda, Beysen, Carine, Hompesch, Marcus, Turner, Scott, Hellerstein, Marc, Banks, Phillip, Strumph, Paul, Lapuerta, Pablo
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Online Only Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067537/
https://ncbi.nlm.nih.gov/pubmed/31837264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgz258
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars